# Matrix Partners China's Biotech Investments: 22 Startups in Its Portfolio (2026) > The 22 Biotech startups Matrix Partners China has backed, by stage: $1.5B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/matrix-partners-china-2-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 10 - [Adlai Nortye](https://millionrounds.com/company/adlai-nortye) - [Senti Biosciences](https://millionrounds.com/company/senti-biosciences) - [D3 Bio](https://millionrounds.com/company/d3-bio) - [Qihan Biotech](https://millionrounds.com/company/qihan-biotech) - [PAQ Therapeutics](https://millionrounds.com/company/paq-therapeutics) - [*1S* 12 Sigma](https://millionrounds.com/company/12-sigma) - [23Mofang](https://millionrounds.com/company/23mofang) - [GrandOmics](https://millionrounds.com/company/grandomics) - [*SB* SA Biotech](https://millionrounds.com/company/sa-biotech) - [Genedock](https://millionrounds.com/company/genedock) ## Series A 5 - [NovoCodex](https://millionrounds.com/company/novocodex) - [*UT* Ucello Therapeutics](https://millionrounds.com/company/ucello-therapeutics) - [NeuraMatrix](https://millionrounds.com/company/neuramatrix) - [*SB* Si'ao Biotechnology](https://millionrounds.com/company/si-ao-biotechnology) - [*U* UmerDoctor](https://millionrounds.com/company/umerdoctor) ## Series C and later 4 - [InventisBio](https://millionrounds.com/company/inventisbio) - [*NB* Nuance Biotech](https://millionrounds.com/company/nuance-biotech) - [Nuance Pharma](https://millionrounds.com/company/nuance-pharma) - [GRIT Biotechnology](https://millionrounds.com/company/grit-biotechnology) ## Stage not reported 3 - [Abc clinic butler](https://millionrounds.com/company/abc-clinic-butler) - [RootPath](https://millionrounds.com/company/rootpath) - [Tallac Therapeutics](https://millionrounds.com/company/tallac-therapeutics) ## Segment by segment ### Series B 10 startups · $629M raised - [**Adlai Nortye**](https://millionrounds.com/company/adlai-nortye) Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types. China $190M - [**Senti Biosciences**](https://millionrounds.com/company/senti-biosciences) Senti Biosciences is a biotechnology company that focuses on synthetic biology and gene circuit engineering for therapeutic applications. United States $169M - [**D3 Bio**](https://millionrounds.com/company/d3-bio) D3 Bio is a clinical-stage biotechnology company based in Wuxi, China, founded in 2020. China $108M - [**Qihan Biotech**](https://millionrounds.com/company/qihan-biotech) Qihan Biotech is a gene-editing organ transplantation technology developer. China $42M - [**PAQ Therapeutics**](https://millionrounds.com/company/paq-therapeutics) PAQ Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020 by Dr. United States $38M - [*1S* **12 Sigma**](https://millionrounds.com/company/12-sigma) United States $30M - [**23Mofang**](https://millionrounds.com/company/23mofang) 23Mofang provides genetic testing services for Chinese people and conducts life data analysis business. China $16M - [**GrandOmics**](https://millionrounds.com/company/grandomics) Grandomics provides molecular diagnosis, research, and carrier screening for single gene diseases. China $15M ### Series A 5 startups · $125M raised - [**NovoCodex**](https://millionrounds.com/company/novocodex) NovoCodex is a biopharmaceuticals company that specalizes in the business of genetic engineering, and cell culture. China $62M - [*UT* **Ucello Therapeutics**](https://millionrounds.com/company/ucello-therapeutics) Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20. China $21M - [**NeuraMatrix**](https://millionrounds.com/company/neuramatrix) NeuraMatrix is a China-based brain-computer interface platform that offers an implantable neural interface for frontier neuroscien China $16M - [*SB* **Si'ao Biotechnology**](https://millionrounds.com/company/si-ao-biotechnology) Si'ao Biotechnology engages in the development and production of genetic engineering vaccines and test kits. China $14M - [*U* **UmerDoctor**](https://millionrounds.com/company/umerdoctor) UmerDoctor is a dermatologist collaborative learning platform. China $13M ### Series C and later 4 startups · $702M raised - [**InventisBio**](https://millionrounds.com/company/inventisbio) InventisBio is a clinical-stage biopharmaceutical company based in Shanghai, China, with operations in New Jersey, USA. China $236M - [*NB* **Nuance Biotech**](https://millionrounds.com/company/nuance-biotech) Nuance Biotech is a pharmaceutical company Based In China. China $201M - [**Nuance Pharma**](https://millionrounds.com/company/nuance-pharma) Nuance Pharma is a specialty biopharmaceutical company based in Shanghai, founded in 2014 by Mark Lotter. China $181M - [**GRIT Biotechnology**](https://millionrounds.com/company/grit-biotechnology) Grit Biotechnology, also known as Grit Bio, is a clinical-stage biopharmaceutical company based in Shanghai, China. China $84M ### Stage not reported 3 startups · $27M raised - [**Abc clinic butler**](https://millionrounds.com/company/abc-clinic-butler) Abc clinic butler is a smart clinic butler service provider. China $14M - [**RootPath**](https://millionrounds.com/company/rootpath) RootPath is a synthetic biology company dedicated to reducing the cost of gene synthesis and enhancing gene function interrogation. United States $8.4M - [**Tallac Therapeutics**](https://millionrounds.com/company/tallac-therapeutics) Tallac Therapeutics offers next generation immunotherapies for cancer patients. United States $5.0M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Matrix Partners China as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Matrix Partners China's AI portfolio** 19 startups · $1.2B](https://millionrounds.com/portfolio-maps/matrix-partners-china-2-ai-portfolio)[Portfolio map **Matrix Partners China portfolio map** 96 startups · $5.2B](https://millionrounds.com/portfolio-maps/matrix-partners-china-2-portfolio-map)[Investments abroad **Matrix Partners China's investments in China** 70 startups · $4.2B](https://millionrounds.com/portfolio-maps/matrix-partners-china-2-investments-china)[Co-investors **Who invests with Matrix Partners China** 50 co-investors](https://millionrounds.com/portfolio-maps/matrix-partners-china-2-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio) ## Raising from investors like Matrix Partners China? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)